FASTinov is a legitimate biotechnology company with high-impact technology (rapid antimicrobial susceptibility testing) that addresses a critical global health issue (AMR). The project has verifiable external traction, including EU funding (~€4.3M), CE Marking, and hospital evaluations. However, the submission itself is of extremely poor quality, containing false claims ('most people have used my product', 'audience: everyone') and vague data. The score reflects the high real-world utility and technical innovation of the actual company, heavily penalized for the misleading and low-effort submission details.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline